The impact of increasing dose on overall survival in prostate cancer.

about

Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy.

P2860

Q37554782-B9EAFEBA-20AA-4164-8882-E952F5E90676 Q38819438-6E9FC275-3046-4926-A0F3-A7F9C3C97240

P2860

The impact of increasing dose on overall survival in prostate cancer.

Item

http://www.wikidata.org/entity/Q35663315

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The impact of increasing dose on overall survival in prostate cancer.

@ast

The impact of increasing dose on overall survival in prostate cancer.

@en

type

Item

label

The impact of increasing dose on overall survival in prostate cancer.

@ast

The impact of increasing dose on overall survival in prostate cancer.

@en

prefLabel

The impact of increasing dose on overall survival in prostate cancer.

@ast

The impact of increasing dose on overall survival in prostate cancer.

@en

P1476

The impact of increasing dose on overall survival in prostate cancer

@en

P2093

Bertrand P Tseng

http://www.w3.org/2001/XMLSchema#string

David D Smith

http://www.w3.org/2001/XMLSchema#string

Jeffrey Y C Wong

http://www.w3.org/2001/XMLSchema#string

Timothy E Schultheiss

http://www.w3.org/2001/XMLSchema#string

P2860

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Radical prostatectomy versus observation for localized prostate cancer.

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Duration of androgen suppression in the treatment of prostate cancer.

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

P2888

s13014-015-0419-3

P304

115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-015-0419-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew D. Hall

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277086062

http://www.w3.org/2001/XMLSchema#string

P6179

1007506512

http://www.w3.org/2001/XMLSchema#string

P698

25990489

http://www.w3.org/2001/XMLSchema#string

P932

4448310

http://www.w3.org/2001/XMLSchema#string

The impact of increasing dose on overall survival in prostate cancer.

about

P2860

P2860

The impact of increasing dose on overall survival in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932